跳至主要内容
临床试验/ISRCTN53060944
ISRCTN53060944已完成不适用

Evaluation of the mucosa-permeability of the stomach measured by the Ussing Chambers technique in patients with functional dyspepsia before and after treatment with amitriptyline

Academic Medical Center (AMC), Department of Gastroenterology (The Netherlands)0 个研究点目标入组 60 人开始时间: 2006年6月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 18-65 years
  • 2. Patients have to take part in the amitriptyline study (ISRCTN76116512)
  • 3. Functional dyspepsia (Nepean dyspepsia index [NDI] >25)
  • 4. No depression (Zung self-rating depression scale <50)
  • 5. No effect on proton pump inhibitor (PPI), or a constant three-month dosage of PPI
  • 6. No medications which will influence the intestine

排除标准

  • 1. Gastroduodenal surgery in history
  • 2. Reflux-like dyspepsia (Rome II criteria)
  • 3. Use of antidepressants
  • 4. Organic abnormalities
  • 5. Severe cardiac, renal, pulmonary, hepatic, or systemic diseases, hyperthyroidism, glaucoma and epilepsy

研究者

发起方
Academic Medical Center (AMC), Department of Gastroenterology (The Netherlands)

相似试验